We found that DSF/Cu up-regulated the expression of CXCL10, CCL5 and IFN-β in multiple high metastatic breast cancer cell lines, which was associated with the activation of the STING-TBK1-IRF3 pathway. This evidence concerns the gene CCL5 and breast cancer.